Teladoc COO resigns amid executive shuffle

Teladoc’s chief operating officer has resigned due to an executive reshuffle, a few months after the company named a new CEO.

COO Michael Waters’ resignation …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Combined General Meeting of June 24, 2024 – Biotech Investments

Biophytis / Key word(s): AGM/EGM/AGM/EGM Combined General Meeting of June 24, 2024 07-Jun-2024 / 07:39 CET/CEST Combined General Meeting of June 24, 2024 Paris

June 8, 2024

Targeted Combination Shows Promise in Metastatic Kidney Cancer

LOUISVILLE, Ky. — More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug combination, which held disease progression at

November 14, 2024

Opinion | The Parasite Heard ‘Round the World

Claire Panosian Dunavan is a professor of medicine and infectious diseases at the David Geffen School of Medicine at UCLA and a past-president of the

October 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.